Cargando…

Prediction of Absorbed Dose to Normal Organs with Endocrine Tumors for I-131 by use of (99m)TC Single Photon Emission Computed Tomography/Computed Tomography and Geant4 Application for Tomographic Emission Simulation

INTRODUCTION: This study aimed to predict the dose absorbed by normal organs with neuroendocrine tumors for (131)I using single photon emission computed tomography/computed tomography (SPECT/CT) images and Geant4 application for tomographic emission (GATE) simulation. MATERIALS AND METHODS: Four to...

Descripción completa

Detalles Bibliográficos
Autores principales: Asl, Rohollah Ghahraman, Sabbaghi, Rezvan, Ahangari, Hadi Taleshi, Hejazi, Payman, Foroutan, Majid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481846/
https://www.ncbi.nlm.nih.gov/pubmed/34658551
http://dx.doi.org/10.4103/ijnm.ijnm_6_21
_version_ 1784576772183949312
author Asl, Rohollah Ghahraman
Sabbaghi, Rezvan
Ahangari, Hadi Taleshi
Hejazi, Payman
Foroutan, Majid
author_facet Asl, Rohollah Ghahraman
Sabbaghi, Rezvan
Ahangari, Hadi Taleshi
Hejazi, Payman
Foroutan, Majid
author_sort Asl, Rohollah Ghahraman
collection PubMed
description INTRODUCTION: This study aimed to predict the dose absorbed by normal organs with neuroendocrine tumors for (131)I using single photon emission computed tomography/computed tomography (SPECT/CT) images and Geant4 application for tomographic emission (GATE) simulation. MATERIALS AND METHODS: Four to 5 whole-body planar scan series, along with one SPECT/CT image, were taken from four patients following (99m)Tc-hynic-Tyr(3)-octreotide radiotracer injection. After image quantification, the residence time of each organ was calculated using the image analysis and the activity time curves. The energy deposit and dose conversion (S-value) were extracted from the GATE simulation for the target organs of each patient. Using the residence times and S-values, the mean absorbed dose for the target organs of each patient was calculated and compared with the data obtained from the standard method. RESULTS: Very close agreement was obtained between the S-value of the self–organ irradiation. The mean percentage difference between the two methods (i.e. GATE and Medical Internal Radiation Dose [MIRD]) was 1.8%, while a weak agreement was observed for cross-organ irradiation. The percentage difference between the total absorbed doses by the organs was 2%. The percentage difference between the absorbed doses obtained for tumors and three considered normal organs estimated by the GATE method was slightly higher than the MIRD method (about 11% on average for tumors). CONCLUSION: Regardless of the small difference between the obtained results for the organs and absorbed doses of the tumors in the present study, patient-specific dosimetry by the GATE methods is useful and essential for therapeutic radionuclides such as (131)I due to high cross-dose effects, especially for young adult patients, to ensure the radiation safety and increase the effectiveness of the treatment.
format Online
Article
Text
id pubmed-8481846
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-84818462021-10-14 Prediction of Absorbed Dose to Normal Organs with Endocrine Tumors for I-131 by use of (99m)TC Single Photon Emission Computed Tomography/Computed Tomography and Geant4 Application for Tomographic Emission Simulation Asl, Rohollah Ghahraman Sabbaghi, Rezvan Ahangari, Hadi Taleshi Hejazi, Payman Foroutan, Majid Indian J Nucl Med Original Article INTRODUCTION: This study aimed to predict the dose absorbed by normal organs with neuroendocrine tumors for (131)I using single photon emission computed tomography/computed tomography (SPECT/CT) images and Geant4 application for tomographic emission (GATE) simulation. MATERIALS AND METHODS: Four to 5 whole-body planar scan series, along with one SPECT/CT image, were taken from four patients following (99m)Tc-hynic-Tyr(3)-octreotide radiotracer injection. After image quantification, the residence time of each organ was calculated using the image analysis and the activity time curves. The energy deposit and dose conversion (S-value) were extracted from the GATE simulation for the target organs of each patient. Using the residence times and S-values, the mean absorbed dose for the target organs of each patient was calculated and compared with the data obtained from the standard method. RESULTS: Very close agreement was obtained between the S-value of the self–organ irradiation. The mean percentage difference between the two methods (i.e. GATE and Medical Internal Radiation Dose [MIRD]) was 1.8%, while a weak agreement was observed for cross-organ irradiation. The percentage difference between the total absorbed doses by the organs was 2%. The percentage difference between the absorbed doses obtained for tumors and three considered normal organs estimated by the GATE method was slightly higher than the MIRD method (about 11% on average for tumors). CONCLUSION: Regardless of the small difference between the obtained results for the organs and absorbed doses of the tumors in the present study, patient-specific dosimetry by the GATE methods is useful and essential for therapeutic radionuclides such as (131)I due to high cross-dose effects, especially for young adult patients, to ensure the radiation safety and increase the effectiveness of the treatment. Medknow Publications & Media Pvt Ltd 2021 2021-09-23 /pmc/articles/PMC8481846/ /pubmed/34658551 http://dx.doi.org/10.4103/ijnm.ijnm_6_21 Text en Copyright: © 2021 Indian Journal of Nuclear Medicine https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Asl, Rohollah Ghahraman
Sabbaghi, Rezvan
Ahangari, Hadi Taleshi
Hejazi, Payman
Foroutan, Majid
Prediction of Absorbed Dose to Normal Organs with Endocrine Tumors for I-131 by use of (99m)TC Single Photon Emission Computed Tomography/Computed Tomography and Geant4 Application for Tomographic Emission Simulation
title Prediction of Absorbed Dose to Normal Organs with Endocrine Tumors for I-131 by use of (99m)TC Single Photon Emission Computed Tomography/Computed Tomography and Geant4 Application for Tomographic Emission Simulation
title_full Prediction of Absorbed Dose to Normal Organs with Endocrine Tumors for I-131 by use of (99m)TC Single Photon Emission Computed Tomography/Computed Tomography and Geant4 Application for Tomographic Emission Simulation
title_fullStr Prediction of Absorbed Dose to Normal Organs with Endocrine Tumors for I-131 by use of (99m)TC Single Photon Emission Computed Tomography/Computed Tomography and Geant4 Application for Tomographic Emission Simulation
title_full_unstemmed Prediction of Absorbed Dose to Normal Organs with Endocrine Tumors for I-131 by use of (99m)TC Single Photon Emission Computed Tomography/Computed Tomography and Geant4 Application for Tomographic Emission Simulation
title_short Prediction of Absorbed Dose to Normal Organs with Endocrine Tumors for I-131 by use of (99m)TC Single Photon Emission Computed Tomography/Computed Tomography and Geant4 Application for Tomographic Emission Simulation
title_sort prediction of absorbed dose to normal organs with endocrine tumors for i-131 by use of (99m)tc single photon emission computed tomography/computed tomography and geant4 application for tomographic emission simulation
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481846/
https://www.ncbi.nlm.nih.gov/pubmed/34658551
http://dx.doi.org/10.4103/ijnm.ijnm_6_21
work_keys_str_mv AT aslrohollahghahraman predictionofabsorbeddosetonormalorganswithendocrinetumorsfori131byuseof99mtcsinglephotonemissioncomputedtomographycomputedtomographyandgeant4applicationfortomographicemissionsimulation
AT sabbaghirezvan predictionofabsorbeddosetonormalorganswithendocrinetumorsfori131byuseof99mtcsinglephotonemissioncomputedtomographycomputedtomographyandgeant4applicationfortomographicemissionsimulation
AT ahangarihaditaleshi predictionofabsorbeddosetonormalorganswithendocrinetumorsfori131byuseof99mtcsinglephotonemissioncomputedtomographycomputedtomographyandgeant4applicationfortomographicemissionsimulation
AT hejazipayman predictionofabsorbeddosetonormalorganswithendocrinetumorsfori131byuseof99mtcsinglephotonemissioncomputedtomographycomputedtomographyandgeant4applicationfortomographicemissionsimulation
AT foroutanmajid predictionofabsorbeddosetonormalorganswithendocrinetumorsfori131byuseof99mtcsinglephotonemissioncomputedtomographycomputedtomographyandgeant4applicationfortomographicemissionsimulation